Adicionando a entrevista motivacional e o mapeamento cognitivo à terapia cognitivo-comportamental em grupo: resultados de um ensaio clínico randomizado by MEYER, Elisabeth et al.
20 • Revista Brasileira de Psiquiatria • vol 32 • nº 1 • Mar2010
Adding motivational interviewing and thought mapping 
to cognitive-behavioral group therapy: results from a 
randomized clinical trial
Adicionando a entrevista motivacional e o mapeamento cognitivo 
à terapia cognitivo-comportamental em grupo: resultados de um 
ensaio clínico randomizado
Correspondence
Elisabeth Meyer
Department of Psychiatry, Universidade Federal do Rio Grande do Sul
R. Ramiro Barcelos, 2350, Room 400N
90035-903 Porto Alegre, RS, Brazil
Phone: (+55 51) 3328-2174 
E-mail: meyer-beth@hotmail.com
Elisabeth Meyer,1 Roseli G. Shavitt,2 Carl Leukefeld,3 Elizeth Heldt,1 Fernanda P. Souza,1 Paulo Knapp,1 
Aristides V. Cordioli1
1 Anxiety Disorders Program, Department of Psychiatry, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre (RS), Brazil 
2 Obsessive-Compulsive Spectrum Disorders Program, Department and Institute of Psychiatry, Hospital das Clínicas, School of Medicine, 
  Universidade de São Paulo (USP), São Paulo (SP), Brazil 
3 Center on Drug and Alcohol Research, University of Kentucky, Lexington, Kentucky, USA
Abstract
Objective: Recent factor-analytic studies of obsessive-compulsive disorder 
identified consistent symptom dimensions. This study was designed 
in order to observe which obsessive compulsive symptom dimensions 
could be changed by adding two individual sessions of motivational 
interviewing and thought mapping of cognitive-behavioral group 
therapy using a randomized clinical trial. Method: Forty outpatients 
with a primary diagnosis of obsessive-compulsive disorder were randomly 
assigned to receive cognitive-behavioral group therapy (control group) or 
motivational interviewing+thought mapping plus cognitive-behavioral 
group therapy. To evaluate changes in symptom dimensions, the 
Dimensional Yale-Brown Obsessive-Compulsive Scale was administered 
at baseline and after treatment. Results: At post-treatment, there were 
statistically significant differences between cognitive-behavioral group 
therapy and motivational interviewing+thought mapping+cognitive-
behavioral group therapy groups in the mean total Dimensional Yale-
Brown Obsessive-Compulsive Scale score, and in the contamination 
and aggression dimension score. Hoarding showed a statistical trend 
towards improvement. Conclusion: These findings suggest that adding 
motivational interviewing+thought mapping to cognitive-behavioral 
group therapy can facilitate changes and bring about a decrease in the 
scores in different obsessive-compulsive disorder symptom dimensions, 
as measured by the Dimensional Yale-Brown Obsessive-Compulsive 
Scale. Nonetheless, additional trials are needed to confirm these results. 
Descriptors: Signs and symptoms; Obsessive-compulsive disorder; 
Cognitive therapy; Behavior therapy; Interview, psychological 
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Resumo
Objetivo: Recentes estudos utilizando análise fatorial no transtorno obsessivo-
compulsivo identificaram dimensões consistentes dos sintomas. Este estudo foi 
delineado para observar quais dimensões dos sintomas obsessivo-compulsivos 
podem ser modificadas adicionando duas sessões individuais de entrevista 
motivacional e mapeamento cognitivo à terapia cognitivo-comportamental em 
grupo usando um ensaio clínico randomizado. Método: Quarenta pacientes 
ambulatoriais com diagnóstico primário de transtorno obsessivo-compulsivo 
foram alocados aleatoriamente para receber terapia cognitivo-comportamental 
em grupo (grupo controle) ou entrevista motivacional+mapeamento 
cognitivo+terapia cognitivo-comportamental em grupo. Para avaliar 
mudanças nas dimensões dos sintomas, foi administrada a Escala Dimensional 
para Sintomas Obsessivo-Compulsivos de Yale-Brown antes do início e 
após o tratamento.  Resultados: Ao final do tratamento houve diferença 
estatisticamente significativa entre a terapia cognitivo-comportamental em 
grupo e entrevista motivacional+mapeamento cognitivo+terapia cognitivo-
comportamental em grupo na média do escore total da Escala Dimensional 
para Sintomas Obsessivo-Compulsivos de Yale-Brown e no escore da dimensão 
de contaminação e agressão. Colecionismo apresentou melhora com tendência 
estatística. Conclusão: Esses achados sugerem que acrescentar entrevista 
motivacional+mapeamento cognitivo à terapia cognitivo-comportamental 
em grupo pode facilitar mudanças na redução dos escores nas diferentes 
dimensões dos sintomas, como indicado pela Escala Dimensional para 
Sintomas Obsessivo-Compulsivos de Yale-Brown. No entanto, são necessários 
estudos adicionais para confirmar estes resultados.
Descritores: Sinais e sintomas; Transtorno obsessivo-compulsivo; Terapia 
cognitiva; Terapia comportamental; Entrevista psicológica
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Introduction
Obsessive-compulsive disorder (OCD) is a chronic disease 
characterized by intrusive thoughts and rituals performed to 
relieve the anxiety or discomfort, although the result is probably 
an increase in distress over time. Several studies have reported 
the importance of groups of symptoms in specific dimensions, 
assuming that patients may present symptoms in one or more 
dimensions, with varying degrees of severity among them.1-3 These 
proposed dimensions are: 1) aggressive obsessions and related 
compulsions (e.g., checking that nothing terrible has happened); 
2) sexual and religious obsessions and related compulsions 
(e.g., excessive concern with what is morally right or wrong); 
3) symmetry, ordering, counting, and arranging obsessions and 
compulsions (e.g., being afraid of not saying “just the right thing”); 
4) contamination obsessions and cleaning compulsions (e.g., 
repeated cleaning of household items or other inanimate objects); 
5) hoarding and collecting obsessions and compulsions (e.g. being 
unable to decide to throw things away), and 6) miscellaneous 
(e.g. ascribing special significance to colors). Researchers4,5 have 
suggested that the dimensional approach might help guide 
research on the treatment of OCD, including the development 
of Cognitive Behavioral Therapy (CBT) techniques tailored to 
specific symptom dimensions, which could  improve response 
rates.6,7 Based on earlier studies using factor analysis to group 
patients with certain obsessive-compulsive (OC) symptoms, 
Rosario-Campos et al.2 developed the Dimensional Yale-Brown 
Obsessive-Compulsive Scale (DY-BOCS).
Although CBT has been shown to be effective for OCD,8,9 
changing ritual behavior can be difficult and anxiety-provoking. 
When OCD patients see possible benefits in stopping the 
rituals, they tend to feel ambivalent towards changing behavior. 
Motivational Interviewing (MI) is an effective strategy for helping 
individuals increase their motivation or readiness to change. MI 
helps the therapist and patient to achieve a common understanding 
about the patient’s awareness of change, facilitating the movement 
through decisional analysis and behavioral change.10,11 Miller 
and Rollnick have described five strategies of MI: 1) express 
empathy and acceptance (i.e., empathy means acceptance and 
understanding another’s perspective and feelings neutrally, without 
judging or evaluating in any way); 2) develop discrepancy (i.e., 
perceive differences between a current situation and hope for the 
future); 3) avoid argumentation (i.e., when the patient refuses to 
complete a task, it is time to stop forcing the point and to modify 
the strategy); 4) roll with resistance (i.e., arguing for change with 
a patient will likely trigger the patient to argue against it), and 5) 
support self-efficacy (i.e., a person’s belief in his or her ability to 
carry out a specific behavior).11 MI can be utilized as independent, 
stand-alone intervention or can be integrated with other treatment 
modalities. Resisting the righting reflex (the “righting reflex” 
refers to our natural urge as human beings to put things right: 
e.g. health care providers are probably more inclined to have a 
righting reflex12), understanding and exploring the patient’s own 
motivations, empowering the patient, encouraging hope and 
optimism, all help a therapist promote collaboration and reduce 
resistance.12 The techniques of MI are described in detail in Miller 
and Rollnick,11 and Rollnick, Miller and Butler.12
Eventually, the inability to concentrate creates difficulties for 
OCD patients in focusing their attention. Some OCD patients 
cannot make the connection between a person’s behavior in the 
context of their environment, thoughts, and feelings and how 
some experiences are related to desirable outcomes, while others 
are related to undesirable ones. Thought Mapping (TM)13,14 was 
developed based on the Transtheoretical Model15 and the first four 
stages of change. It is a visual technique that uses a predesigned 
map and is very useful in keeping individual discussions on track. 
Because the aspects worked on during the session can be visualized, 
TM might be particularly helpful for patients who are engaged 
in mental ritual activity and/or have been presenting excessive 
uncertainty or doubt about what was said, during the consultation 
with the mental health professional. The use of visual aids (paper 
and pen) in TM may help the patient focus on the intervention. 
A personal “thought map”, for OCD-related dysfunctional 
thoughts and behaviors is developed by each patient to organize 
his or her own personal thoughts and behaviors. In doing this, 
patients can express parallel ideas, complex and distant thoughts, 
and connections between behaviour and feelings. It can also help 
patients identify more clearly where changes need to take place, 
to explore behavioral choices and subsequent results, and to 
consider solutions to the presenting problem. The TM technique 
is described in detail in Leukefeld et al.16
The overall purpose of the present study was to examine if 
adding two individual sessions of MI+TM before starting 12 weeks 
of CBGT in an adult OCD outpatient treatment program would 
facilitate changes in the OC symptom dimensions when compared 
with CBGT alone, as measured by a structured interview, in a 
randomized clinical trial.
Method
1. Participants
Sixty-five adult outpatients meeting DSM-IV criteria for OCD, 
as determined by the Brazilian version17 of  Structured Clinical 
Interviews (SCID)18 for DSM-IV attending an Anxiety Disorders 
Program (PROTAN) in Porto Alegre, Brazil, were assessed from 
January 2007 to December 2007 (see Figure 1). Participants were 
recruited among the general population by means of lectures, 
radio and TV interviews, and newspaper advertisements that 
offered CBGT to patients with OCD. Interviews were conducted 
by trained psychiatrists or clinical psychologists, experienced in 
treating OCD patients. Inclusion criteria based on assessment 
included: 1) age between 18 and 65 years old; 2) having OCD as 
the most significant current psychiatric diagnosis; 3) Yale-Brown 
Obsessive-Compulsive Scale (Y-BOCS) total score > 16; and 4) 
no change in anti-obsessive medication (if applicable) for at least 
three months prior to study entry. Consistent with our previous 
researches,19-21 individuals were excluded from the current study 
if they had an additional diagnosis of another anxiety or mood 
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disorder of equal or greater severity than their OCD, significant 
suicidality, present alcohol or substance abuse or dependence, or 
severe psychiatric disorder (schizophrenia and other psychotic 
disorders). Twenty-five patients were determined not eligible. 
The reasons for exclusion were: Severe Depression (n = 9), 
severe social phobia (n = 3), personality disorders: borderline or 
schizotypical (n = 3), substance abuse (n = 2), bipolar disorder 
(n = 2), schizophrenia (n = 1), or a score < 16 on the Y-BOCS 
(n = 5). After signing an informed consent form, 40 selected 
patients were randomized: 20 patients (50%) to MI+TM+CBGT 
group and 20 patients (50%) to the control group. Of the 40 
outpatients who composed the sample, 38 completed the study. 
Two patients (5%) dropped out of the control group after the third 
session (they contacted the therapist to state that they would no 
longer attend the sessions). 
2. Study design and procedures
Randomization of the MI+TM+CBGT group or the control 
group was performed using a research randomizer (see: www.
randomizer.org/index.htm). The study was conducted in three 
successive periods of 12 weeks, with one MI+TM+CBGT and one 
parallel information-only condition plus CBGT (control group). 
Participants in both the MI+TM and control groups received the 
CBGT as usual; they differed only in the style of individual sessions 
received prior to CBGT. The individual interventions were carried 
out by a doctoral-level therapist, who did not participate in the 
CBGT sessions. CBGT had six to eight patients, and sessions were 
conducted by the same therapist, assisted by a co-therapist, both 
masters-level student psychologists with prior CBGT experience, 
who were blinded to the individual interventions. Patients were 
also instructed not to reveal the content of their individual sessions. 
The CBGT was conducted in a closed-ended group during the 
course of 12 weekly two-hour sessions, carried out once a week, 
over three months. The treatment approach integrated psycho-
education, techniques of Exposure and Response Prevention 
(ERP), cognitive techniques to modify dysfunctional thoughts 
and beliefs, strategies to prevent relapses, homework ERP and 
cognitive exercises for each session, and group techniques.  
The Hospital de Clínicas of Porto Alegre review board 
approved the study (Process:06 /171). Written informed 
consent was obtained from all participants, after a description 
of the study, emphasizing that they would be randomized into 
one of two treatment conditions: 1) two individual sessions of 
MI+TM+CBGT, or 2) two information-only condition sessions 
plus CBGT (the control). Each participant was assured that their 
decision to participate or not participate in the study would not 
interfere with their access to treatment. 
3. Treatment
1) Cognitive behavioral group therapy (CBGT) 
The CBGT was conducted in a closed-ended group during the 
course of 12 weekly two-hour sessions, based on a structured manual-
based approach developed by one of the authors (AVC), and has been 
used in other trials.19-21 The treatment started with a presentation 
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of OCD symptoms, the rationale of ERP therapy and treatment 
targets, followed by demonstrations and practical ERP exercises. In 
the subsequent sessions, commonly held dysfunctional beliefs about 
OCD were explained and cognitive techniques for their correction 
were given, followed by practical exercises in ERP and cognitive 
restructuring. At the end of each session, homework was given to each 
patient.19,22 The manual is described in detail elsewhere.22 
2) Motivational Interviewing (MI) + Thought Mapping (TM) 
plus CBGT group
The MI+TM approach consisted of two 60-minute individual 
weekly sessions before the patients started the 12 CBGT sessions. 
The interventions were carried out by a doctoral-level therapist, 
who did not participate in the CBGT sessions. The two sessions are 
designed to allow the patient to discover what he or she can expect 
from the treatment, as well as increasing the motivation for change 
in a collaborative process involving the therapist and patient. No 
manual was given, allowing the therapist autonomy to follow the 
patient using MI strategies. The sessions were patient-centered, 
used open-ended and non-confrontational questions, to encourage 
patients to talk about why, how and when they might change, 
reinforcing the idea that the focus of behavior change resides in 
the patient, not in the therapist. A key goal in MI is to increase the 
importance of change from the patient’s perspective. In CBT, the 
therapist takes the role of an advocate for change, to at least some 
degree, but in MI, the therapist does not argue in favor of change, 
but helps the patient to become a more effective advocate for their 
own change.23 Rollnick12 points out that if the patient is placed 
center stage, and guided through a conversation about why and 
how to change, outcomes will be improved. The two individual 
sessions were structured as: 1) identifying and exploring reasons 
for change; 2) helping the patient to acknowledge and discuss 
their mixed feelings about possible benefits in stopping the rituals, 
thereby tipping the balance in favor of change (e.g., “How do you 
think your life might be different, both positively, and negatively, 
if you were to stop the rituals?”); 3) using reflective listening when 
trying to express patient understanding (e.g., “So you’re saying 
that you want to stop all the rituals, but, at the same time, you’re 
worried whether you can deal with the anxiety during the therapy 
exercises”); 4) inviting the patient to define goals (e.g. invite the 
person to describe perceived barriers/concerns changing); 5) 
reflecting and summarizing concerns raised by the patient during 
the decision-making process; 6) choosing personal strategies (e.g., 
“If you decided to change how would you do it?”). The purpose 
of this intervention model was that of exploring and resolving 
ambivalence in avoiding rituals, and to increase and renew patient 
motivation or readiness to adhere to the ERP exercises which are 
part of CBGT. It was also to help strengthen the patient’s self-
efficacy (e.g. identify existing skills and how to generalize those 
to the OCD context) and in addition, the therapist explained 
the CBGT model, explained ERP, and encouraged each patient 
to tolerate and manage anxiety provoked by ERP. 
For this study, the therapist and the patient completed a map 
together and patients were encouraged to analyze their TM and to 
develop strategies to face the anxiety produced by their obsessions with 
alternative behavioral responses. TM is a structured and preformatted 
mapping approach to link nodes (visually represented as boxes) as 
feelings, thoughts, and actions in treatment sessions with links (visually 
represented by lines) to show relationships on paper between nodes. 
Utilizing TM allows the patient to see the role of thoughts/ beliefs/ 
feelings and behavior and the influences working among them all. 
The first part of the map (Figure 2) was used to facilitate problem 
recognition and identification (questions 1-3: ANTECEDENTS):
The second part (questions 4-6; Figure 3) was for problem 
solutions: CONSEQUENCES, as showed above:
3) Two-session individual information-only condition plus 
CBGT (control group)
In order to control the attention, duration and time spent in 
contact with the therapist treating the MI+TM condition, we 
created a comparison condition. The control condition was two 
60-minute individual weekly sessions before the 12 sessions of 
CBGT and was administered by one doctoral-level therapist who 
did not participate in the group sessions. As an information-only 
condition, the therapist provided information about smoking 
cessation (session 1), and educational physical activity (session 2). 
Sessions were conducted in the style of a lecture and presented 
information such as: a) passive smoking exposure causes heart 
disease and lung cancer in non-smoking adults; b) exposure to 
nicotine and passive smoking is measured by testing the saliva, 
urine, or blood for the presence of a chemical called cotinine; c) 
most adults need at least 30 minutes of moderate physical activity 
at least five days per week; d) for all individuals, some activity is 
better than none. Regular exercise can prevent or delay diabetes 
and heart trouble. Participants could ask questions at any time. In 
the information-only condition, non-motivational interviewing 
components or TM were used, and presumably the intervention 
did not focus on enhancing commitment to change. 
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3. Statistical analysis
Shapiro-Wilk tests of the distribution of data were performed, 
as well as analysis to look for differences by type of condition 
(MI+TM+CBGT vs control group) across all key variables 
with t-tests, one-way ANOVA, Mann-Whitney test or 
Wilcoxon test for continuous variables, and Pearson χ2 test for 
nominal variables. We used non-parametric statistics whenever 
appropriate. The comparison of pre- and post-treatment scores 
was performed using t-test paired samples or with McNemar 
Chi-Square test. Analyses of covariance (ANCOVA) were used 
to control potential confounding variables. A positive response 
to treatment was defined as 35% or greater reduction in baseline 
Y-BOCS scores. Pearson χ2 test was used for dichotomic data: 
improved (reduction ≥ 35% on the Y-BOCS) versus non-improved 
(reduction ≤ 35% on the Y-BOCS). Patients who responded to 
treatment were also classified as having full remission for YBOCS 
scores ≤ 8 and CGI = 1 and partial remission when there was a 
reduction ≥ 35% on the Y-BOCS, but the total score on this 
scale was > 8 and CGI = 2. To compare the changes in symptom 
dimensions from baseline to post-treatment, the results obtained 
from the two groups (MI+TM+CBGT and CBGT) were analyzed 
in two ways: 1) by comparing the DY-BOCS scores (reduction) 
by dimension, and 2) by noting the frequency (according to their 
presence or absence) of symptoms by dimension. The presence 
of a symptom dimension on the DY-BOCS was coded as 1 while 
its absence was coded as 0. DY-BOCS scores on six symptom 
dimensions were calculated by summing the scores from the sym 
ptom categories under each dimension. This score was used in 
all subsequent analyses. To verify which dimensions improve 
more and by how much, in both groups, a Δspecification of the 
change was applied to generate the data presented on Table 1. The 
mean of the deltas represents the overall average of the individual 
deltas of each patient, which was calculated using the following 
equation: Δmean= (post-treatment value – pre-treatment value) / 
(pre-treatment value). Rates were compared across the two groups 
with the Pearson χ2 test. The last-observation-carried-forward 
approach was adopted for continuous data. An intention-to-treat 
approach was used for patients who dropped out, labeled non-
improved. All p-values were two-tailed, the statistical significance 
was set at the 0.05 level and the confidence level was 95%. 
Statistical assessments were performed by the Statistical Package 
for Social Sciences for Windows, version 13.0.
2. Assessments
Participants completed the following measures at baseline and 
post-treatment to evaluate outcome. The DY-BOCS2 includes a 
self-report section and an interviewer-administered section. The 
scale was simultaneously validated in Portuguese and English, 
and examines OC symptoms on six specific dimensions: 1) 
obsessions about harm due to aggression/injury/violence/natural 
disasters and related compulsions; 2) obsessions concerning 
sexual/moral/religious and related compulsions; 3) obsessions 
about symmetry/‘just-right’ perceptions, and compulsions 
to count or order/arrange; 4) contamination obsessions and 
cleaning compulsions; 5) obsessions and compulsions related 
to hoarding, and 6) miscellaneous obsessions and compulsions 
that relate to somatic concerns and superstitions, amongst other 
symptoms. This instrument measures the severity of each symptom 
dimension. For each dimension, there are three questions with a 
0-5 point rating scale to measure time consumed by the symptoms, 
distress and interference (maximum score in each dimension = 15). 
This interview assesses lifetime, current severity, and age at 
onset. Therefore, the baseline and post-treatment severity of each 
dimension were measured independently.
The Brazilian version24 of the Y-BOCS25 was used to assess 
severity of OCD symptoms, and included 10 questions: five for 
obsessions and five for compulsions, including time taken up 
by the symptoms, the level of interference in daily activities and 
distress, resistance and control of symptoms. Each item was scored 
from 0 to 4 with a maximum score of 40.
The Clinical Global Impressions Scale - Severity subscore 
(CGI-S, adapted version)26 investigates the health professional’s 
impression of the severity of the patient’s problem.
These instruments were administered by independent 
evaluators at baseline (before the two individual sessions) and 
after completing CBGT, by masters-level psychologists, trained 
on the application of the instruments, with experience in treating 
OCD patients, and blinded to group allocation. Every patient was 
reviewed at baseline and post-treatment by the same evaluator, in 
order to minimize the inter-rater variability.
Patients were also assessed with regard to their sociodemographic 
and clinical characteristics, including age, gender, years of 
education, marital status, use of anti-obsessional drugs, age at 
onset, age at which OCD symptoms started to interfere with daily 
activities, and the duration of the illness. 
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Results
1. Baseline data
The sample included 13 (65%) women in the MI+TM+CBGT 
and 15 (75%) women in the control group, aged 18-65 years. 
Seventeen of the patients were married, the largest group 
(42.5%). Fifteen (37.5%) participants were single, seven (17.5%) 
were divorced and one (2.5%) was widowed. There was no 
significant difference in the distribution of male and female 
patients across the groups (p = 0.730) or significant difference 
in the marital status (p = 0.225) of the two groups. Twenty-eight 
patients (70%) met criteria for comorbid psychiatric disorders, 
including major depressive disorder (n = 16; 40%), social phobia 
(n = 12; 30%), simple phobia (n = 10; 25%), compulsive buying 
(n = 5; 12.5%), skin picking (n = 5; 12.5%) and posttraumatic 
stress disorder (n = 3; 7.5%). No evidence of mismatch was 
observed at baseline between the MI+TM+CBGT and the 
control group for demographic and clinical characteristics. The 
main demographic and clinical characteristics of the sample are 
described in Table 2.
When OCD symptom dimensions were examined using the 
DY-BOCS, 34 (85%) patients reported symmetry, order and 
arrangement symptoms; 29 (72.5%) miscellaneous symptoms; 24 
(60.5%) had aggression symptoms; 23 (57.5%) contamination, 
cleaning and washing symptoms; 23 (57.5%) hoarding symptoms, 
and seven (12.5%) sexual–religious symptoms. There were no 
statistically significant differences between the MI+TM+CBGT 
group and the control group for mean DY-BOCS total score at 
baseline (t = -1.50, df = 38, p = 0.142) or when each dimension 
was considered separately: aggression dimension (χ2 = 0.100, 
df = 1, p = 0.747); sexual/religious dimension (χ2 = 0.173, df = 1, 
p = 0.677); symmetry dimension (χ2 = 0.000, df = 1, p = 1.000); 
contamination dimension (χ2 = 0.102, df = 1, p = 0.749); hoarding 
dimension (χ2 = 0.102, df = 1, p = 0.749) and the miscellaneous 
dimension (χ2 = 3.135, df = 1, p = 0.077).
Mean Y-BOCS baseline scores (t = -1.02, df = 38, p = 0.313), 
Y-BOCS Obsessions subscale (t = -1.12, df = 38, p = 0.271) and 
Y-BOCS Compulsions subscale (t = -0.16, df = 38, p = 0.871) for 
the MI+TM+CBGT group and the control group were similar, 
and did not differ for those receiving concurrent anti-obsessive 
medication relative to those who were not (p = 0.442).
2. Treatment response
Results of pre/post-treatment outcome measures for the 
MI+TM+CBGT and the control groups are presented in Table 3. 
The comparison of mean rate of improvement, accessed by 
the average of the Δmean of all outcome variables between 
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MI+TM+CBGT group and control group at the end of the 
treatment are presented in Table 1.
Discussion
The present study examined which obsessive compulsive 
symptom dimensions could be changed by adding two individual 
sessions of MI+TM before CBGT. Participants in both the 
MI+TM and control conditions received the CBGT. The 
treatments differed in the type of individual sessions received prior 
to CBGT. Usually, OCD patients believe that using rituals can 
be a helpful strategy to manage the anxiety that arises from feared 
situations. MI+TM was used to inform patients that the most 
effective way to reduce their fear is to confront the feared situations 
in which they experienced obsessions, without performing any 
rituals, and to wait for the reduction of anxiety. MI+TM might 
help patients to explore and resolve their ambivalence about 
whether or not to utilize rituals. MI+TM explicitly address 
motivation to change before CBGT, and assist the patient in how 
to make the best use of CBGT. TM ensures that patients receive 
an individualized case formulation and that the rationale for the 
ERP is thoroughly understood. In contrast, the control group did 
not explicitly focus on enhancing commitment to change at the 
outset. Therefore we conclude that since the MI+TM treatment 
encourages patients to change it resulted in better outcomes.
At baseline, symmetry, order and arrangement were the 
most prevalent symptom dimension in both groups, and were 
phenomenologically similar to previous trials.2,6,27,28 In a recent 
article, Leckman et al. reported that CBT is mostly indicated 
for patients with symmetry/ordering, contamination/washing, 
and aggressive/checking symptoms.29 Studies from Mataix-Cols 
et al. suggest that the presence of symmetry/ordering symptoms 
predicted better response in refractory cases.30
CBGT was effective for most symptom dimensions of OCD. 
Both groups have been shown to be effective in reducing the DY-
BOCS global score and five of the dimension scores. Therefore 
CBGT might be indicated for patients with contamination, 
aggressive, symmetry, hoarding and miscellaneous symptoms. 
Nevertheless, the rate of reduction in the DY-BOCS global score 
and each dimension score (except the sexual/religious dimension) 
were significantly higher in patients treated with MI+TM+CBGT. 
As shown in Table 1, at the end of the treatment, the group 
MI+TM+CBGT showed significant improvement in the 
dimensions of aggression and contamination, compared to CBGT 
alone. Hoarding showed a statistical trend towards improvement. 
Similarly, the DY-BOCS total score showed a statistical trend 
towards improvement. The CGI for the MI+TM+CBGT group 
showed a mean rate of improvement with a statistical trend. As 
Miller described, motivational interviewing can synergistically 
amplify the effect of other treatments.31 The combined effects of 
individualized treatment with elements of MI and TM obviously 
have had a large synergetic effect on the group intervention. These 
modifications suggest that changes in the dimensions were not 
just associated with global improvement of OCD, but could be 
associated with the addition of MI+TM to CBGT. One possibility 
would be that MI+TM helps patients to “think through” the 
pros (or benefits) and cons (or costs) of a particular belief or 
behavior in order to learn more about what they would identify 
as an important issue. After reflecting they can identify their own 
individual problem-solving strategies. 
Clinical implications of this study indicate that special attention 
should be paid to patients with the dimension of sexual/religious 
symptoms. At pre- to post-treatment, there were no significant 
differences in the scores for the sexual/religious symptom 
dimension for patients treated with MI+TM+CBGT and for those 
in the control condition, which supports previous studies.4,32 Our 
findings suggest that patients with sexual/religious symptoms may 
have more difficulty with CBGT than other OCD patients. One 
possible explanation for our findings is that patients with sexual/
religious symptoms may have more difficulty recognizing the 
irrational nature of their symptoms than other patients, and as 
a result, these symptoms are more difficult to challenge. Fullana 
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et al.3 and Mataix-Cols et al.4 point out that sexual or religious 
obsessions have been strongly associated with poor treatment 
response in previous studies and might be less likely to respond 
to serotonin reuptake inhibitors (SRIs) and behavior therapy. 
Therefore, more specific treatment strategies tailored for the 
sexual/religious symptom dimension are probably necessary. Other 
studies,33,34 however, did not confirm these findings. 
In this study, patients with hoarding symptoms tended to 
improve more with MI+TM+CBGT as compared with those in 
the control group. It could be speculated that MI+TM might 
bring additional benefits to CBGT. Our results are in line with 
other studies that suggest that hoarders can be more successfully 
treated with a multifaceted cognitive-behavioural intervention 
than with regular CBT.32
There were no significant differences in the Y-BOCS total 
scores, but we observed a statistical tendency for improvement 
in the MI+TM+CBGT group compared to CBGT alone. 
Interestingly, the Y-BOCS compulsion score was significantly 
improved in the MI+TM+CBGT group compared to CBGT 
alone. It is important to point out that the improvement in 
compulsion is an extremely relevant result for this study. A possible 
explanation may be that the addition of MI+TM to CBGT may 
exert most of its impact on those dimensions which have a more 
“compulsive” component. This is in agreement with the finding 
that the dimensions which improved most were contamination 
(i.e., hand washing, avoidance) and aggression (i.e., checking in 
order to prevent unwanted outcomes or to make sure one did 
not harm anybody). One of the goals of the MI+TM individual 
sessions was to encourage the patients, prior to the CBGT, to face 
the expected increase in anxiety experienced during the OCD 
prevention exercises (ERP). Moreover, the individual sessions 
were also used to give the patients in the MI+TM+CBGT group 
explanations about how avoiding the use of rituals will gradually 
diminish the frequency of obsessions as well as the suffering elicited 
by them. Thus, the improvement in compulsion suggests that the 
intervention, i.e. MI+TM session, accomplished its objective, 
which was to focus on ameliorating the compulsions. 
Although these results seem promising, important limitations 
of the present study must be considered. Firstly, a selection bias 
could account for the exceptionally large treatment effect size 
obtained in this study. Specifically, differently from other clinical 
studies, patients that presented several comorbidities were excluded 
from the sample. The severity of the comorbidities that were in 
fact present, such as depression and social phobia, was mild. In 
addition, the screening process involved selecting patients who 
were particularly motivated to participate in group therapy. The 
selection of highly motivated patients is evident since the drop-
out rate was considerably smaller than other similar studies have 
previously reported. Thus, the selection bias and the small sample 
size, which render our findings susceptible of statistical errors, 
limit the use of our results to extrapolate the outcome of using the 
treatment strategies employed in this study. However, even if our 
results may not represent the entire OCD patient population, this 
does not undermine the contribution of our findings to the field, 
given that it is the first time that MI+TM have been used before 
CBGT to compare the changes in obsessive-compulsive symptoms 
according to six different dimensions in the treatment of OCD. 
Future studies using different exclusion criteria, screening processes 
and larger sample sizes may show different results. The use of MI 
and TM may be effective in treating a different sample although 
the size of the treatment effect may not be as large as the one 
obtained in this study. The strength of this study is its randomized 
clinical trial design. Future research is needed to expand the present 
findings: for instance, how the elements specific to the MI-TM 
intervention might have influenced the response to CBGT and 
which components of MI-TM are most prominent. The lack of 
discriminative measures of the MI and TM interventions makes 
it difficult to determine which of these interventions is/are 
responsible for the results. Secondly, assessments did not include 
instruments to measure possible confounding factors such as 
motivation to change, fear, adherence to treatment or homework 
compliance. As a result, the outcomes may not generalize to the 
OCD adult outpatients as a whole. It is important to note that, 
although the stages of change have not been systematically assessed, 
the way a patient responds to interventionist feedback in relation 
to problem behavior offers strong evidence about the patient’s 
motivation and readiness to change that behavior.31 Thirdly, we 
recognize the limitations that arise from the DY-BOCS not yet 
having a cut-off point for the global score and each dimension 
since it could lead to the inclusion of subclinical symptoms in 
some dimensions. However, in this study, we aimed to investigate 
whether adding two individual sessions of MI+TM to CBGT, 
which is a completely novel approach that has not been employed 
in the treatment of OCD, would influence the outcome of the 
treatment by affecting the scores of several dimensions of OCD 
symptoms compared to CBGT alone. Finally, the absence of 
long-term follow-up data limits our findings. Future studies are 
needed to evaluate the stability of the therapeutic benefits over 
time. Despite these limitations, this is the first randomized study 
which uses MI+TM before CBGT to compare the changes in OC 
symptom dimensions and it represents an important contribution 
to our knowledge regarding the treatment of OCD.
To conclude, this study used a Motivational Interviewing and 
Thought Mapping approach which is not routinely employed in 
OCD treatment programs. The results indicate beneficial effects 
of adding MI+TM to CBGT for OCD adult outpatients. 
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